GlassScriptPhysician profile
Hassan Hussain
NPI 1962485938
$25,285.83
in general payments reported to CMS, 2019-2025
19 companies · $7,230 in 2025
The $7,230 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,391 · 2020: $107 · 2021: $401 · 2022: $5,180 · 2023: $10K · 2024: $738 · 2025: $7,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,270 · Long Term Medical Supply Or Device Loan: $5,783 · Food and Beverage: $3,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,269.99 |
| Long Term Medical Supply Or Device Loan | $5,783.33 |
| Food and Beverage | $3,153.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,664.16 | 2021-2025 | In.Pact Admiral, Crome Dr Mri Surescan, Reveal Linq |
| Angiodynamics, INC. | $9,469.96 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $2,457.78 | 2021-2025 | Gallant, Aveir, Confirm Rx |
| Medtronic Vascular, INC. | $1,029.63 | 2019-2020 | |
| Edwards Lifesciences Corporation | $677.43 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $193.42 | 2020-2023 | Impella |
| Shockwave Medical, INC | $164.90 | 2021-2025 | |
| Boston Scientific Corporation | $156.66 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Latitude Communicator Power Supply |
| Janssen Pharmaceuticals, INC | $119.34 | 2019 | |
| W. L. Gore & Associates, INC. | $100.23 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Biotronik INC. | $73.44 | 2022-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Pfizer INC. | $48.20 | 2019-2024 | |
| Gilead Sciences, INC. | $24.27 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.85 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.71 | 2023-2025 | Lifevest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.71 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.99 | 2019 | |
| Chiesi USA, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.